Breast screening review--a radiologist's perspective.

Recently published articles in the lay press and scientific journals have questioned the value of breast screening, and have raised concerns about both possible harmful effects and the information provided for females when they receive their screening invitation. A review of data from screening trials and the process for providing information for the public on screening has been announced by Professor Sir Mike Richards, National Clinical Director for Cancer. What are the major issues involved and what expectations should radiologists and other members of the screening team have of the review?